Position in EVO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$38,068
-$12,219 QoQ
Shares Held
13,596
-32.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 34 holders
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in EVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vanguard Personalized Indexing Management, LLC holds $33,072,704 across 32 Drug Manufacturers - Specialty & Generic names. EVO ranks #28 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
333,247 | $4,828,749 | |
| 2 | VTRS |
Viatris Inc
|
284,926 | $4,524,624 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
7,747 | $4,197,557 | |
| 4 | ZTS |
Zoetis Inc.
|
53,516 | $3,845,659 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
127,525 | $2,044,225 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
11,004 | $1,854,614 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
74,835 | $1,841,689 | |
| 8 | HLN |
Haleon plc
|
174,951 | $1,632,292 |
All Filings in EVO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,068 | 13,596 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $50,287 | 20,115 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $32,863 | 10,670 | Shares | Sole | 2026-02-13 | |
| 2024-12-31 | $53,397 | 12,836 | Shares | Sole | 2025-02-10 | |
| 2024-06-30 | $92,318 | 19,233 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||